Top story · sciencescience
FDA milestone for first canine longevity drug brings lifespan research into focus
A first-of-its-kind dog-ageing programme reached an FDA milestone, with the agency indicating a reasonable expectation of effectiveness — a step toward conditional approval. Veterinarians caution that no anti-ageing drug is yet available and that proven longevity levers remain weight management, dental care and routine vet visits. Owners interested in senior-pet health should speak with their vet rather than wait for future therapies.
Unsplash
Read full story ↗